✦ LIBER ✦

Pegylated interferon α enhances recovery of memory T cells in e antigen positive chronic hepatitis B patients

✍ Scribed by Yong Zhe Liu, Feng Qin Hou, Peng Ding, Yuan Yuan Ren, Shi Hong Li, Gui Qiang Wang

Book ID: 119908646
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 892 KB
Volume: 9
Category: Article
ISSN: 1743-422X
DOI: 10.1186/1743-422x-9-274

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison between quantitative hepatiti

Comparison between quantitative hepatitis B surface antigen, hepatitis B e-antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-α-2b therapy in hepatitis B e-antigen-positive chronic hepatitis B

✍ Pisit Tangkijvanich; Piyawat Komolmit; Varocha Mahachai; Pattaratida Sa-nguanmoo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB

Potent hepatitis B surface antigen respo

Potent hepatitis B surface antigen response to treatment of hepatitis-B-e-antigen-positive chronic hepatitis B with α-interferon plus a nucleos(t)ide analog

✍ Xinyue Chen; Zhenhuan Cao; Yali Liu; Hongwei Zhang; Yonghong Zhang; Lina Ma; Yi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 764 KB

Interferon α-2b with and without ribavir

Interferon α-2b with and without ribavirin in the treatment of hepatitis B e antigen–positive chronic hepatitis B: A randomized study

✍ Chun-Jen Liu; Ming-Yang Lai; You-Chen Chao; Li-Ying Liao; Sien-Sing Yang; Tun-Je 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

To study whether interferon (IFN) ␣ and ribavirin combination therapy has a beneficial effect for hepatitis B e antigen (HBeAg)-positive chronic hepatitis B, we enrolled 119 such patients in a randomized study. Fifty-nine patients received 5 million units of IFN-␣2b daily for 4 weeks followed by 5 m

α-2-HS-glycoprotein is a potential marke

α-2-HS-glycoprotein is a potential marker predicting hepatitis B e antigen seroconversion in patients with chronic hepatitis B during treatment with pegylated interferon alfa-2b

✍ Hui Ma; JiangHua Wang; Fang Guo; Lai Wei 📂 Article 📅 2011 🏛 Science in China Press (SCP) 🌐 English ⚖ 719 KB

Dynamics of memory T cells during treatm

Dynamics of memory T cells during treatment with interferon-alpha in patients with chronic hepatitis B

✍ Bin Sun; Yanjun Wang; Qinghua Meng; Daojie Liu; Peiling Dong; Huiguo Ding; Hao W 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB

A randomized controlled trial of thymosi

A randomized controlled trial of thymosin-α1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody—and hepatitis B virus DNA—positive chronic hepatitis B

✍ P Andreone; C Cursaro; A Gramenzi; C Zavaglia; I Rezakovic; E Altomare; R Severi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

ment for anti-HBe-positive chronic hepatitis. The benefit It has recently been shown that thymosin-a 1 (T-a 1 ), a of this agent in producing long-term inhibition of HBV synthetic polypeptide of thymic origin, is able to proreplication must be confirmed by future trials. (HEPAmote disease remission